Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics' products treat bacterial AND viral infectious disease through a common mechanism of action in the host.

  • Stage $3M in TTM Revenue
  • Industry Biotechnology
  • Location Atlanta, GA, USA
  • Currency USD
  • Founded September 2008
  • Employees 5
  • Website inhibikase.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free